Latest News about MESO
Recent news which mentions MESO
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 08, 2023
From Benzinga
Mesoblast, Arlo Technologies, CPI Card Group And Other Big Stocks Moving Higher On Wednesday
March 08, 2023
From Benzinga
Mesoblast's Lead Drug Candidate Goes Under FDA Priority Review For Bone Marrow Transplant Complications In Kids
March 08, 2023
Tickers
MESO
From Benzinga
From Benzinga
Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
March 08, 2023
From Benzinga
From InvestorPlace
Dow Dips 300 Points; Snap Shares Plunge
February 01, 2023
From Benzinga
Silicon Laboratories, Credit Acceptance, Stryker And Other Big Stocks Moving Higher On Wednesday
February 01, 2023
From Benzinga
US Stocks Open Lower; Dow Drops 125 Points
February 01, 2023
From Benzinga
Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session
November 30, 2022
From Benzinga
Workday, XPeng, Titan Machinery And Some Other Big Stocks Moving Higher On Wednesday
November 30, 2022
From Benzinga
Mesoblast Lead Product Shows Durable Long-Term Survival At Four Years In Kids With Graft Versus Host Disease
November 23, 2022
Tickers
MESO
From Benzinga
A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field
October 13, 2022
From Benzinga
From Benzinga
Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session
October 03, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022
September 06, 2022
From Benzinga
From InvestorPlace
Mesoblast Limited (MESO) Q1 2022 Earnings Call Transcript
March 28, 2022
Tickers
MESO
From Motley Fool
87 Biggest Movers From Yesterday
March 10, 2022
From Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
March 09, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 16, 2021
From Benzinga
FDA's Office Agrees On 12-Month Reduction In Pain As Primary Endpoint For Mesoblast's Back Pain Study
December 16, 2021
Tickers
MESO
From Benzinga
The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street
December 16, 2021
From Benzinga
46 Biggest Movers From Yesterday
December 16, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 15, 2021
From Benzinga
36 Stocks Moving In Wednesday's Mid-Day Session
December 15, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.